http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103356637-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2013-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103356637-B |
| titleOfInvention | Chaetocin is preparing the application in prevention and therapy cardiotropic formulation |
| abstract | The invention discloses chaetocin and prepare the application in prevention and therapy cardiotropic formulation, show through experimentation, chaetocin significantly can improve degree of myocardial fibrosis, improve the cardiac function that high pressure load brings out, prevent myocardial hypertrophy and remodeling ventricle, delay the generation of heart failure, and the myocardial cell oxidative stress caused by acute myocardial infarction can be suppressed, reduce ischemic infarction area, reduce myocardial cell oxidative stress, maintain myocardial cell normal function, delay the generation of heart failure, show the cardiopathic effect of good prevention and therapy, and have no obvious adverse reaction in experimentation, be expected to the medicine being developed to safe and effective control heart disease of new generation. |
| priorityDate | 2013-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.